Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases
About This Grant
Project Summary/Abstract: This application requests travel support for early-career investigators, graduate students, and postdoctoral fellows to attend the FASEB Scientific Research Conference “GI Tract XXII: Molecular and Cellular Advances Towards Discovery and Treatment,” to be held August 30–September 3, 2026, in Snowbird, Utah. The meeting is designed to prepare the next generation of researchers focused on GI health and disease and developing new treatments. The organizers include investigators funded by NIDDK that share a commitment to advancing innovative science that improves digestive health. The FASEB GI conference series has been held biennially since 1985, supporting idea exchange, collaboration, and mentoring within the GI research community. The field has advanced rapidly with breakthroughs in multi-omics, organoid systems, single-cell and spatial transcriptomics, stem cell biology, and new therapeutics, and leaders in these areas will serve as keynote and session speakers. A core goal of the meeting is to intentionally include early-career researchers, providing them with oral and poster presentation opportunities, structured career development and networking sessions, and workshops designed to enhance rigor and reproducibility across NIDDK-funded studies. To ensure broad participation, we seek funding to offset travel costs for trainees and early-career investigators. While virtual platforms have expanded opportunities for cross-institutional collaboration, in-person scientific conferences remain essential for initiating new collaborations, fostering mentorship, and strengthening community bonds within the GI research field. As organizers representing both MD and PhD scientists, we are committed to fostering interdisciplinary collaboration and supporting the next generation of digestive disease researchers.
Grant Summary
Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment is a NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases grant providing up to $52K for university, nonprofit, healthcare org. Applications are due 2027-07-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $52K
2027-07-31
- 1Confirm your organization is eligible for Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment: Frequently Asked Questions
Who is eligible for the Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment?
Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment is offered by NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment provide?
Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment provides up to $52K per award from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment deadline?
Applications for Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment are due 2027-07-31 (open). Because deadlines can change, verify the date with the funder, NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment?
To apply for Gastrointestinal Tract XXII Molecular and Cellular Advances Towards Discovery and Treatment, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases.